I just mean from the perspective of avoiding the obligations of the CN. I know that is academic. 10% of our investment will be going to meeting those obligations. If the trials don't add to the sp then that is a dead loss to all of us. Having said that GK holding such an interest may be worth it.
If it were me I'd do Anisina first, if only because the KCP is contributing so much to that. It just hypo.
Good luck.
NRT Price at posting:
10.3¢ Sentiment: Buy Disclosure: Held
